LAIR-1 Antibodies

Santa Cruz Biotechnology delivers a wide array of LAIR-1 monoclonal antibodies for research focused on leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1) in immune regulation. LAIR-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). LAIR-1 functions as an inhibitory receptor expressed on immune cells, playing a significant role in modulating immune responses and maintaining tolerance. Through binding to collagen and other extracellular matrix components, LAIR-1 helps regulate the activation and proliferation of immune cells, which is essential for preventing autoimmune diseases and maintaining homeostasis. Understanding LAIR-1 function is vital for developing therapeutic strategies targeting immune-related disorders. Researchers can investigate LAIR-1's role in various cellular pathways and signaling mechanisms using specific detection methods. Advanced research techniques allow for detailed examination of LAIR-1 expression patterns across different cell types and tissues. Exploring LAIR-1's interactions with various binding partners provides insights into immune system regulation. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of immune system regulation and potential therapeutic applications.